These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6411812)

  • 41. Extent of morphological differentiation of human melanoma cells reflected by HLA-DR antigen profiles.
    Liao SK; Kawakubo Y; Smith JW; Singal DP; Wong YH
    Prog Clin Biol Res; 1985; 172B():355-66. PubMed ID: 3857636
    [No Abstract]   [Full Text] [Related]  

  • 42. A possible new HLA-DR allele.
    Betuel H; Gebuhrer L; Lambert J; Freidel AC; Farre A
    Hum Immunol; 1983 Nov; 8(3):227-37. PubMed ID: 6196341
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemizygous HLA mutants of lymphoblastoid cells: a new cell type for histocompatibility testing.
    Kavathas P; DeMars R; Bach FH
    Hum Immunol; 1980 Dec; 1(4):317-24. PubMed ID: 6167551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The use of cellular reagents as an adjunct to typing for HLA-DRw10.
    Ball EJ; Stastny P
    Tissue Antigens; 1984 Sep; 24(3):155-9. PubMed ID: 6334904
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of HLA specificity LB-E12 (MB1, DC1, MT1) with lepromatous leprosy in a Venezuelan population.
    Ottenhoff TH; Gonzalez NM; de Vries RR; Convit J; van Rood JJ
    Tissue Antigens; 1984 Jul; 24(1):25-9. PubMed ID: 6592792
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular genetics of HLA-DR 'Br': allogenotypes of DR1 and DR'Br' are indistinguishable.
    Bidwell JL; Jarrold EA; Laundy GJ; Klouda PT; Bradley BA
    Tissue Antigens; 1986 Feb; 27(2):99-101. PubMed ID: 3486500
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New HLA-D alleles associated with DR1 and DR2.
    Suciu-Foca N; Godfrey M; Khan G; Woodward K; Rohowsky C; Reed E; Hardy M; Reemtsma K
    Tissue Antigens; 1981 Mar; 17(3):294-302. PubMed ID: 6458923
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ultrastructural localization of antigens recognized by the monoclonal antibodies MB1, MB2, MT1, UCHL1, and TAL 1B5.
    Butler MG; Wells C; d'Ardenne AJ
    Ultrastruct Pathol; 1988; 12(3):301-5. PubMed ID: 3165229
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human allospecific TLCs generated against HLA antigens associated with DR1 through DRw8. III. Family segregation analyses.
    Rosen-Bronson S; Johnson AH; Hartzman RJ; Eckels DD
    Immunogenetics; 1988; 27(1):31-9. PubMed ID: 3257098
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of HLA-like structures on a permanent human tumor line PC-93.
    Claas FH; van Steenbrugge GJ
    Tissue Antigens; 1983 Mar; 21(3):227-32. PubMed ID: 6602397
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel HLA-D/DR-like antigen specific for human B lymphoid cells. Biochemical evidence for similarity to but nonidentity with known HLA-D/DR antigens.
    Marti GE; Kuo MC; Shaw S; Chang CC; Demars R; Sogn JA; Coligan JE; Kindt TJ
    J Exp Med; 1983 Dec; 158(6):1924-37. PubMed ID: 6606012
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recombination within the HLA-D region. Correlation of molecular genotyping with functional data.
    Robinson MA; Long EO; Johnson AH; Hartzman RJ; Mach B; Kindt TJ
    J Exp Med; 1984 Jul; 160(1):222-38. PubMed ID: 6330268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular localization of human class II MT2 and MT3 determinants.
    Hurley CK; Giles RC; Nunez G; DeMars R; Nadler L; Winchester R; Stastny P; Capra JD
    J Exp Med; 1984 Aug; 160(2):472-93. PubMed ID: 6206179
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Refinement of HLA gene mapping with induced B-cell line mutants.
    Spring B; Fonatsch C; Müller C; Pawelec G; Kömpf J; Wernet P; Ziegler A
    Immunogenetics; 1985; 21(3):277-91. PubMed ID: 3872842
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Natural killer susceptibility of human cells may be regulated by genes in the HLA region on chromosome 6.
    Harel-Bellan A; Quillet A; Marchiol C; DeMars R; Tursz T; Fradelizi D
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5688-92. PubMed ID: 2426704
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dissociation in expression of MB1/MT1 and DR1 alloantigens in mutants of a lymphoblastoid cell line.
    DeMars R; Chang CC; Marrari M; Duquesnoy RJ; Noreen H; Segall M; Bach FH
    J Immunol; 1983 Sep; 131(3):1318-21. PubMed ID: 6411812
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dissection of the D-region of the human major histocompatibility complex by means of induced mutations in a lymphoblastoid cell line.
    DeMars R; Chang CC; Rudersdorf RA
    Hum Immunol; 1983 Oct; 8(2):123-39. PubMed ID: 6417067
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
    Maeda H; Hirata R
    J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular, serologic, and functional evidence for an apparent HLA-DR triplet.
    Bontrop RE; Schreuder GM; Elferink DG; Mikulski MM; Geerse R; Giphart MJ
    J Immunol; 1986 Jul; 137(1):211-6. PubMed ID: 3486913
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.